Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Cancer. 2011 Dec 12;118(7):1925–1932. doi: 10.1002/cncr.26432

Table 3.

Adjusted Cognitive Domain T-score Means and Standard Errors by Groupa

Measure CT
RT
NC
T1 T2 T1 T2 T1 T2
Attention 52.47 (0.78) 53.55 (0.72) 50.82 (0.74) 51.59 (0.68) 51.33 (0.44) 51.78 (0.41)
Executive functioning 50.42 (0.83) 51.87 (0.81) 51.16 (0.79) 52.30 (0.77) 52.74 (0.48) 54.63 (0.46)
Non-verbal memory 53.02 (0.92) 56.24 (0.95) 51.95 (0.87) 54.97 (0.90) 52.86 (0.52) 55.90 (0.54)
Processing speed 50.24 (0.81) 49.90 (0.84) 49.04 (0.76) 49.03 (0.80) 49.84 (0.46) 51.38 (0.48)
Verbal memory 49.47 (1.26) 50.67 (1.11) 47.72 (1.19) 50.75 (1.05) 46.95 (0.72) 51.26 (0.63)

CT group, patients treated with chemotherapy plus radiotherapy; RT group, patients treated with radiotherapy only; NC group, non-cancer participants; CVLT, California Verbal Learning Test; COWA, Controlled Oral Word Association Test; WMS, Wechsler Memory Scales-III; WAIS, Wechsler Adult Intelligence Scale-III

a

T-score means are adjusted for age, T1 NART scores, and time from T1 to T2 assessments

HHS Vulnerability Disclosure